This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Immunization  • Alert me on articles by topic

JAMA. 2007;298(21):2475-2476.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2007;56:880-885

3 tables omitted

The National Immunization Survey (NIS) provides vaccination coverage estimates among children aged 19-35 months for each of the 50 states and selected urban and county areas.* This report describes the findings of the 2006 NIS, which indicated increases in national coverage with pneumococcal conjugate vaccine (PCV) and varicella vaccine (VAR) and a stable coverage level for the 4:3:1:3:3:1 vaccine series (i.e., 4 doses of diphtheria, tetanus toxoid, and any acellular pertussis vaccine [DTaP]; 3 doses of poliovirus vaccine; 1 dose of measles, mumps, and rubella vaccine [MMR]; 3 doses of Haemophilus influenzae type b [Hib] vaccine; 3 doses of hepatitis B vaccine [HepB]; and 1 dose of VAR). However, national coverage estimates remained below the Healthy People 2010 target of 90% coverage for PCV, DTaP, and VAR and below the 80% target for the 4:3:1:3:3:1 vaccine series.¹ No significant racial/ethnic disparities in 4:3:1:3:3:1 series . . . [Full Text of this Article]

Reported by: